Compared to non-carriers, the age of disease onset is older for patients with PSP carrying LRRK2 gene mutations (mean: 72.3 years), with the predominant clinical phenotype being parkinsonism, frequently leading to an initial misdiagnosis of PD [118]. This evidence concerns the gene LRRK2 and supranuclear palsy, progressive, 1.